BSEBoard Meeting3d ago · 29 Aug 2026, 06:02 pm

Submission of outcome of the board meeting.

Novelix Pharmaceuticals Ltd · 536565

✦ AI SummaryMgmt Change

Novelix Pharmaceuticals Ltd has announced the outcome of its board meeting, which was held on August 29, 2026. The board has approved the appointment of Gnana Prakash Gattu as a whole-time director of the company, effective from August 29, 2026. The company has also announced the date of its annual general meeting, which will be held on September 30, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 29Th August, 2026

Attachments (1)

📄

fb8e0015-ef4c-4e5d-b8c1-98b04d18ec40.pdf

pdf

Download →
View document text
nffi*#kffi,w** Date: 29tt August, 2026 The Deputy Manager Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Sub: Outcome of Board Meeting held on Saturday, 29th August, 2026 pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Ref: Scrip Code: 586565 Scrip ld: NOVELIX Respected Sir/ Madam, This is to inform that Board of Directors of the Company in their meeting held on Saturday, 29th August, 2026 at the registered office of the company i.e. H No: 3-6-237 /610,Flat No: 610. 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029, which commenced at 3:00 P.M. has Considered and Approved: 1. The Board Report along with all other necessary Annexure for the financial year ended March 31, 2026. The Draft Notice for convening the Annual General Meeting (AGM). The 32.a Annual General Meeting of the Company to be convened on, Wednesday, 30tt' September 2026 at 03:00 P.M., through Video ConJerencing/ Other Audio Visual Means (OAVM) in compliance with the applicable provisions of the Companies Act, 2013 read with MCA General Circulars in this regard. 4. Closure of the Register of members and share transfer books of the Company from Thursday 24tn September, 2026 to Wednesday 30th September, 2026 lor holding Annual General Meeting. 5. Appointment of M/s. Bharat Khaniwal & Co., Practicing Company Secretary (Membership No.: A29085), as the Scrutinizer to Scrutinize the Voting through "Remote E voting" and "E- voting during the AGM" for ensuing Annual Genetal Meeting. Cut-off date for determining the eligibility to vote by electronic means for the purpose of Annual General Meeting shall be Wednesday 23,4 September, 2026. The appointment of Gnana Prakash Gattu (DIN:00517921) as Who of the Company w.e.f. 29rh August, 2026; The Meeting was concluded at 04:55 P.M. with the vote of thanks. Novelix Pharmaceuticals Iimited (Formerly Known as TRI URTHI LllrlTED) H No: l-6-217/61o, Flat No: 61o, 6rh Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +9r 8977611o44 Email: novelixpharmaceuti(als@gmail.com www.novelixpharma.com \4 gfraxmateuticata Aloaelin timitut ;lr5' - (FormerlyTR|MURTH|LtirlTED)CtN:167120TG1994p1C018956 i\ \ I I l\ i.n,c,,i r\l.irllrilrr'li We request you to take the aforesaid information on record for dissemination through your website. Thanking you, Yours Faithfully, For Novelix Venkateshwarlu (Whole-time DIN: 02076871 Annexure I Novelix Pharmaceuticals limited (Formerly Known as TRI URTHI LllrilTED) H No: 3-6'217161o, Flat No: 610, 6rh Floor, Lingapur LA Builders, AIso Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +91 8977611o44 Email: novelixpharmaceuticats@gmail.com www.novelixpharma.com ;t *Kff^(kffiffi",w*u, Details as required as per Regulation 30 of SEBI (LODR) Regulations,20l5 read with SEBI Master circular no. Hol49ll4l14(7)2025-cFD-poD2fi13762t2026 dated January 30,2026: Sr. No. Disclosure Requirement Details I Reason for change viz. Change in Mr. Gnana Prakash Gattu is appointed Designation as Whole time director of the company with effect from 29th August, 2026. 2. Date of appointment & 29th August, 2026 Term of Appointment Mr. Gnana Prakash Gattu is appointed as Whole time director of the company for a period of 5 years subject to approval of the members of the Company in the ensuing annual general meeting. J. Name of the listed entities in which Ni1 resigning director holds directorship including category of directorship and membership of committee, if any 4. Brief Profile (ln case ofappointment) Mr. Gattu Gnana Prakash is a graduate from llT-Chennai and having more than 25 years of experience in management and information technology. 5. Disclosure of Relationship between Mr. Gattu Gnana Prakash is not related Directors {in case of appointment of to any of the Directors or Key Director) Managerial Personnel. Mr. Gattu Gnana Prakash belongs to Promoters and Promoter group of the Company. 6. Information as required under BSE Mr. Gattu Gnana Prakash is not circular no. LIST/COMP/1412018- debarred from holding the office of 19. dated June 20, 2018. Director by any SEBI order or any other such authority. t"r,\ryffi Novelix Pharmaceuticals limited (Forme y Known as TRIMURTHI LllrlITED) H Not 3-6-2371610, Flat No: 61o, 6rh Floor, Lingapur tA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +91 8977631c44 EmaiL novelixpharmaceuticals@gmait.com www.novelixpharma.com